Adamson Jones acquires life science specialist Symbiosis IP
12 Oct 2022
Acquisition
Adamson Jones, part of Gateley, the legal and professional services group, has acquired Symbiosis IP Limited.
Founded in 2008 by directors Julie Myint and Rob Docherty, Symbiosis is a chartered patent attorney firm specialising in IP services for the life sciences industry.
Alongside Adamson Jones, the acquisition of Symbiosis enhances the development of complementary business services with an IP and brands focus. Gateley aims to build an industry relevant patent and trademark attorney offering via a mix of acquisitive and organic growth, and by adding new patent specialisms and geographical areas.
Symbiosis has offices in Evesham as well as Cardiff, York, and Sheffield. These are geographically aligned to several UK universities that lead in the industry fields in which they specialise. The team has a track record of supporting innovation coming out of those university incubators and has been involved with early-stage university IP transfers, as well as advising large multinational pharma and biotech groups.
Simon Cooper, director of Adamson Jones, said: “Symbiosis enhances the IP and patent services offered by Adamson Jones’ core offering in medical devices, engineering, electronics, and software. We are very much looking forward to working together and drawing on each other’s strengths and expertise to develop this important area of work for Gateley.”
Julie Myint, director at Symbiosis IP, added: “The staff at Symbiosis are delighted to announce they have joined legal and professional services group, Gateley. This is a very positive strategic move to enable us to grow with the support of Gateley which includes Adamson Jones, a firm of Patent and trademark attorneys with expertise in fields that complements our work in the Life Sciences. With our new colleagues we plan to increase our organic growth whilst continuing to provide our clients with a highly professional and cost-competitive specialised service.”
Rod Waldie, chief executive officer of Gateley, commented: "I am delighted to welcome Symbiosis to the Group. This strategic acquisition will extend the reach of our offering in IP, patents and trademark work across our consultancy and legal services teams that operate in this field and where we believe there is potential for further development.”
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.